Global Gene Therapy in CNS Disorder Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Gene Therapy in CNS Disorder market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Gene Therapy in CNS Disorder is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Gene Therapy in CNS Disorder is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Gene Therapy in CNS Disorder is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Gene Therapy in CNS Disorder players cover Voyager Therapeutics, Spark Therapeutics, Novartis AG, Bluebird Bio Inc. and Biogen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Gene therapy entails the specific transfer of genetic information into affected cells and tissues in order to restore function in diseased areas.
LPI (LP Information)' newest research report, the “Gene Therapy in CNS Disorder Industry Forecast” looks at past sales and reviews total world Gene Therapy in CNS Disorder sales in 2022, providing a comprehensive analysis by region and market sector of projected Gene Therapy in CNS Disorder sales for 2023 through 2029. With Gene Therapy in CNS Disorder sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Therapy in CNS Disorder industry.
This Insight Report provides a comprehensive analysis of the global Gene Therapy in CNS Disorder landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gene Therapy in CNS Disorder portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Therapy in CNS Disorder market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Therapy in CNS Disorder and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Therapy in CNS Disorder.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapy in CNS Disorder market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
The global Gene Therapy in CNS Disorder market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Gene Therapy in CNS Disorder is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Gene Therapy in CNS Disorder is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Gene Therapy in CNS Disorder is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Gene Therapy in CNS Disorder players cover Voyager Therapeutics, Spark Therapeutics, Novartis AG, Bluebird Bio Inc. and Biogen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Gene therapy entails the specific transfer of genetic information into affected cells and tissues in order to restore function in diseased areas.
LPI (LP Information)' newest research report, the “Gene Therapy in CNS Disorder Industry Forecast” looks at past sales and reviews total world Gene Therapy in CNS Disorder sales in 2022, providing a comprehensive analysis by region and market sector of projected Gene Therapy in CNS Disorder sales for 2023 through 2029. With Gene Therapy in CNS Disorder sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Therapy in CNS Disorder industry.
This Insight Report provides a comprehensive analysis of the global Gene Therapy in CNS Disorder landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gene Therapy in CNS Disorder portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Therapy in CNS Disorder market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Therapy in CNS Disorder and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Therapy in CNS Disorder.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapy in CNS Disorder market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Viral Gene Therapy
- Non-viral Gene Therapy
- Alzheimer's Disease
- Huntington's Disease
- Parkinson's Disease
- Batten Disease
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Voyager Therapeutics
- Spark Therapeutics
- Novartis AG
- Bluebird Bio Inc.
- Biogen
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene Therapy in CNS Disorder Market Size 2018-2029
2.1.2 Gene Therapy in CNS Disorder Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Gene Therapy in CNS Disorder Segment by Type
2.2.1 Viral Gene Therapy
2.2.2 Non-viral Gene Therapy
2.3 Gene Therapy in CNS Disorder Market Size by Type
2.3.1 Gene Therapy in CNS Disorder Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Gene Therapy in CNS Disorder Market Size Market Share by Type (2018-2023)
2.4 Gene Therapy in CNS Disorder Segment by Application
2.4.1 Alzheimer's Disease
2.4.2 Huntington's Disease
2.4.3 Parkinson's Disease
2.4.4 Batten Disease
2.5 Gene Therapy in CNS Disorder Market Size by Application
2.5.1 Gene Therapy in CNS Disorder Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Gene Therapy in CNS Disorder Market Size Market Share by Application (2018-2023)
3 GENE THERAPY IN CNS DISORDER MARKET SIZE BY PLAYER
3.1 Gene Therapy in CNS Disorder Market Size Market Share by Players
3.1.1 Global Gene Therapy in CNS Disorder Revenue by Players (2018-2023)
3.1.2 Global Gene Therapy in CNS Disorder Revenue Market Share by Players (2018-2023)
3.2 Global Gene Therapy in CNS Disorder Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE THERAPY IN CNS DISORDER BY REGIONS
4.1 Gene Therapy in CNS Disorder Market Size by Regions (2018-2023)
4.2 Americas Gene Therapy in CNS Disorder Market Size Growth (2018-2023)
4.3 APAC Gene Therapy in CNS Disorder Market Size Growth (2018-2023)
4.4 Europe Gene Therapy in CNS Disorder Market Size Growth (2018-2023)
4.5 Middle East & Africa Gene Therapy in CNS Disorder Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Gene Therapy in CNS Disorder Market Size by Country (2018-2023)
5.2 Americas Gene Therapy in CNS Disorder Market Size by Type (2018-2023)
5.3 Americas Gene Therapy in CNS Disorder Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Therapy in CNS Disorder Market Size by Region (2018-2023)
6.2 APAC Gene Therapy in CNS Disorder Market Size by Type (2018-2023)
6.3 APAC Gene Therapy in CNS Disorder Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene Therapy in CNS Disorder by Country (2018-2023)
7.2 Europe Gene Therapy in CNS Disorder Market Size by Type (2018-2023)
7.3 Europe Gene Therapy in CNS Disorder Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene Therapy in CNS Disorder by Region (2018-2023)
8.2 Middle East & Africa Gene Therapy in CNS Disorder Market Size by Type (2018-2023)
8.3 Middle East & Africa Gene Therapy in CNS Disorder Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE THERAPY IN CNS DISORDER MARKET FORECAST
10.1 Global Gene Therapy in CNS Disorder Forecast by Regions (2024-2029)
10.1.1 Global Gene Therapy in CNS Disorder Forecast by Regions (2024-2029)
10.1.2 Americas Gene Therapy in CNS Disorder Forecast
10.1.3 APAC Gene Therapy in CNS Disorder Forecast
10.1.4 Europe Gene Therapy in CNS Disorder Forecast
10.1.5 Middle East & Africa Gene Therapy in CNS Disorder Forecast
10.2 Americas Gene Therapy in CNS Disorder Forecast by Country (2024-2029)
10.2.1 United States Gene Therapy in CNS Disorder Market Forecast
10.2.2 Canada Gene Therapy in CNS Disorder Market Forecast
10.2.3 Mexico Gene Therapy in CNS Disorder Market Forecast
10.2.4 Brazil Gene Therapy in CNS Disorder Market Forecast
10.3 APAC Gene Therapy in CNS Disorder Forecast by Region (2024-2029)
10.3.1 China Gene Therapy in CNS Disorder Market Forecast
10.3.2 Japan Gene Therapy in CNS Disorder Market Forecast
10.3.3 Korea Gene Therapy in CNS Disorder Market Forecast
10.3.4 Southeast Asia Gene Therapy in CNS Disorder Market Forecast
10.3.5 India Gene Therapy in CNS Disorder Market Forecast
10.3.6 Australia Gene Therapy in CNS Disorder Market Forecast
10.4 Europe Gene Therapy in CNS Disorder Forecast by Country (2024-2029)
10.4.1 Germany Gene Therapy in CNS Disorder Market Forecast
10.4.2 France Gene Therapy in CNS Disorder Market Forecast
10.4.3 UK Gene Therapy in CNS Disorder Market Forecast
10.4.4 Italy Gene Therapy in CNS Disorder Market Forecast
10.4.5 Russia Gene Therapy in CNS Disorder Market Forecast
10.5 Middle East & Africa Gene Therapy in CNS Disorder Forecast by Region (2024-2029)
10.5.1 Egypt Gene Therapy in CNS Disorder Market Forecast
10.5.2 South Africa Gene Therapy in CNS Disorder Market Forecast
10.5.3 Israel Gene Therapy in CNS Disorder Market Forecast
10.5.4 Turkey Gene Therapy in CNS Disorder Market Forecast
10.5.5 GCC Countries Gene Therapy in CNS Disorder Market Forecast
10.6 Global Gene Therapy in CNS Disorder Forecast by Type (2024-2029)
10.7 Global Gene Therapy in CNS Disorder Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Voyager Therapeutics
11.1.1 Voyager Therapeutics Company Information
11.1.2 Voyager Therapeutics Gene Therapy in CNS Disorder Product Offered
11.1.3 Voyager Therapeutics Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Voyager Therapeutics Main Business Overview
11.1.5 Voyager Therapeutics Latest Developments
11.2 Spark Therapeutics
11.2.1 Spark Therapeutics Company Information
11.2.2 Spark Therapeutics Gene Therapy in CNS Disorder Product Offered
11.2.3 Spark Therapeutics Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Spark Therapeutics Main Business Overview
11.2.5 Spark Therapeutics Latest Developments
11.3 Novartis AG
11.3.1 Novartis AG Company Information
11.3.2 Novartis AG Gene Therapy in CNS Disorder Product Offered
11.3.3 Novartis AG Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Novartis AG Main Business Overview
11.3.5 Novartis AG Latest Developments
11.4 Bluebird Bio Inc.
11.4.1 Bluebird Bio Inc. Company Information
11.4.2 Bluebird Bio Inc. Gene Therapy in CNS Disorder Product Offered
11.4.3 Bluebird Bio Inc. Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Bluebird Bio Inc. Main Business Overview
11.4.5 Bluebird Bio Inc. Latest Developments
11.5 Biogen
11.5.1 Biogen Company Information
11.5.2 Biogen Gene Therapy in CNS Disorder Product Offered
11.5.3 Biogen Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Biogen Main Business Overview
11.5.5 Biogen Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene Therapy in CNS Disorder Market Size 2018-2029
2.1.2 Gene Therapy in CNS Disorder Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Gene Therapy in CNS Disorder Segment by Type
2.2.1 Viral Gene Therapy
2.2.2 Non-viral Gene Therapy
2.3 Gene Therapy in CNS Disorder Market Size by Type
2.3.1 Gene Therapy in CNS Disorder Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Gene Therapy in CNS Disorder Market Size Market Share by Type (2018-2023)
2.4 Gene Therapy in CNS Disorder Segment by Application
2.4.1 Alzheimer's Disease
2.4.2 Huntington's Disease
2.4.3 Parkinson's Disease
2.4.4 Batten Disease
2.5 Gene Therapy in CNS Disorder Market Size by Application
2.5.1 Gene Therapy in CNS Disorder Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Gene Therapy in CNS Disorder Market Size Market Share by Application (2018-2023)
3 GENE THERAPY IN CNS DISORDER MARKET SIZE BY PLAYER
3.1 Gene Therapy in CNS Disorder Market Size Market Share by Players
3.1.1 Global Gene Therapy in CNS Disorder Revenue by Players (2018-2023)
3.1.2 Global Gene Therapy in CNS Disorder Revenue Market Share by Players (2018-2023)
3.2 Global Gene Therapy in CNS Disorder Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE THERAPY IN CNS DISORDER BY REGIONS
4.1 Gene Therapy in CNS Disorder Market Size by Regions (2018-2023)
4.2 Americas Gene Therapy in CNS Disorder Market Size Growth (2018-2023)
4.3 APAC Gene Therapy in CNS Disorder Market Size Growth (2018-2023)
4.4 Europe Gene Therapy in CNS Disorder Market Size Growth (2018-2023)
4.5 Middle East & Africa Gene Therapy in CNS Disorder Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Gene Therapy in CNS Disorder Market Size by Country (2018-2023)
5.2 Americas Gene Therapy in CNS Disorder Market Size by Type (2018-2023)
5.3 Americas Gene Therapy in CNS Disorder Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Therapy in CNS Disorder Market Size by Region (2018-2023)
6.2 APAC Gene Therapy in CNS Disorder Market Size by Type (2018-2023)
6.3 APAC Gene Therapy in CNS Disorder Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene Therapy in CNS Disorder by Country (2018-2023)
7.2 Europe Gene Therapy in CNS Disorder Market Size by Type (2018-2023)
7.3 Europe Gene Therapy in CNS Disorder Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene Therapy in CNS Disorder by Region (2018-2023)
8.2 Middle East & Africa Gene Therapy in CNS Disorder Market Size by Type (2018-2023)
8.3 Middle East & Africa Gene Therapy in CNS Disorder Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE THERAPY IN CNS DISORDER MARKET FORECAST
10.1 Global Gene Therapy in CNS Disorder Forecast by Regions (2024-2029)
10.1.1 Global Gene Therapy in CNS Disorder Forecast by Regions (2024-2029)
10.1.2 Americas Gene Therapy in CNS Disorder Forecast
10.1.3 APAC Gene Therapy in CNS Disorder Forecast
10.1.4 Europe Gene Therapy in CNS Disorder Forecast
10.1.5 Middle East & Africa Gene Therapy in CNS Disorder Forecast
10.2 Americas Gene Therapy in CNS Disorder Forecast by Country (2024-2029)
10.2.1 United States Gene Therapy in CNS Disorder Market Forecast
10.2.2 Canada Gene Therapy in CNS Disorder Market Forecast
10.2.3 Mexico Gene Therapy in CNS Disorder Market Forecast
10.2.4 Brazil Gene Therapy in CNS Disorder Market Forecast
10.3 APAC Gene Therapy in CNS Disorder Forecast by Region (2024-2029)
10.3.1 China Gene Therapy in CNS Disorder Market Forecast
10.3.2 Japan Gene Therapy in CNS Disorder Market Forecast
10.3.3 Korea Gene Therapy in CNS Disorder Market Forecast
10.3.4 Southeast Asia Gene Therapy in CNS Disorder Market Forecast
10.3.5 India Gene Therapy in CNS Disorder Market Forecast
10.3.6 Australia Gene Therapy in CNS Disorder Market Forecast
10.4 Europe Gene Therapy in CNS Disorder Forecast by Country (2024-2029)
10.4.1 Germany Gene Therapy in CNS Disorder Market Forecast
10.4.2 France Gene Therapy in CNS Disorder Market Forecast
10.4.3 UK Gene Therapy in CNS Disorder Market Forecast
10.4.4 Italy Gene Therapy in CNS Disorder Market Forecast
10.4.5 Russia Gene Therapy in CNS Disorder Market Forecast
10.5 Middle East & Africa Gene Therapy in CNS Disorder Forecast by Region (2024-2029)
10.5.1 Egypt Gene Therapy in CNS Disorder Market Forecast
10.5.2 South Africa Gene Therapy in CNS Disorder Market Forecast
10.5.3 Israel Gene Therapy in CNS Disorder Market Forecast
10.5.4 Turkey Gene Therapy in CNS Disorder Market Forecast
10.5.5 GCC Countries Gene Therapy in CNS Disorder Market Forecast
10.6 Global Gene Therapy in CNS Disorder Forecast by Type (2024-2029)
10.7 Global Gene Therapy in CNS Disorder Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Voyager Therapeutics
11.1.1 Voyager Therapeutics Company Information
11.1.2 Voyager Therapeutics Gene Therapy in CNS Disorder Product Offered
11.1.3 Voyager Therapeutics Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Voyager Therapeutics Main Business Overview
11.1.5 Voyager Therapeutics Latest Developments
11.2 Spark Therapeutics
11.2.1 Spark Therapeutics Company Information
11.2.2 Spark Therapeutics Gene Therapy in CNS Disorder Product Offered
11.2.3 Spark Therapeutics Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Spark Therapeutics Main Business Overview
11.2.5 Spark Therapeutics Latest Developments
11.3 Novartis AG
11.3.1 Novartis AG Company Information
11.3.2 Novartis AG Gene Therapy in CNS Disorder Product Offered
11.3.3 Novartis AG Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Novartis AG Main Business Overview
11.3.5 Novartis AG Latest Developments
11.4 Bluebird Bio Inc.
11.4.1 Bluebird Bio Inc. Company Information
11.4.2 Bluebird Bio Inc. Gene Therapy in CNS Disorder Product Offered
11.4.3 Bluebird Bio Inc. Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Bluebird Bio Inc. Main Business Overview
11.4.5 Bluebird Bio Inc. Latest Developments
11.5 Biogen
11.5.1 Biogen Company Information
11.5.2 Biogen Gene Therapy in CNS Disorder Product Offered
11.5.3 Biogen Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Biogen Main Business Overview
11.5.5 Biogen Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Gene Therapy in CNS Disorder Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Viral Gene Therapy
Table 3. Major Players of Non-viral Gene Therapy
Table 4. Gene Therapy in CNS Disorder Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Gene Therapy in CNS Disorder Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Gene Therapy in CNS Disorder Market Size Market Share by Type (2018-2023)
Table 7. Gene Therapy in CNS Disorder Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Gene Therapy in CNS Disorder Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Gene Therapy in CNS Disorder Market Size Market Share by Application (2018-2023)
Table 10. Global Gene Therapy in CNS Disorder Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Gene Therapy in CNS Disorder Revenue Market Share by Player (2018-2023)
Table 12. Gene Therapy in CNS Disorder Key Players Head office and Products Offered
Table 13. Gene Therapy in CNS Disorder Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Gene Therapy in CNS Disorder Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Gene Therapy in CNS Disorder Market Size Market Share by Regions (2018-2023)
Table 18. Global Gene Therapy in CNS Disorder Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Gene Therapy in CNS Disorder Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Gene Therapy in CNS Disorder Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Gene Therapy in CNS Disorder Market Size Market Share by Country (2018-2023)
Table 22. Americas Gene Therapy in CNS Disorder Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Gene Therapy in CNS Disorder Market Size Market Share by Type (2018-2023)
Table 24. Americas Gene Therapy in CNS Disorder Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Gene Therapy in CNS Disorder Market Size Market Share by Application (2018-2023)
Table 26. APAC Gene Therapy in CNS Disorder Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Gene Therapy in CNS Disorder Market Size Market Share by Region (2018-2023)
Table 28. APAC Gene Therapy in CNS Disorder Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Gene Therapy in CNS Disorder Market Size Market Share by Type (2018-2023)
Table 30. APAC Gene Therapy in CNS Disorder Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Gene Therapy in CNS Disorder Market Size Market Share by Application (2018-2023)
Table 32. Europe Gene Therapy in CNS Disorder Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Gene Therapy in CNS Disorder Market Size Market Share by Country (2018-2023)
Table 34. Europe Gene Therapy in CNS Disorder Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Gene Therapy in CNS Disorder Market Size Market Share by Type (2018-2023)
Table 36. Europe Gene Therapy in CNS Disorder Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Gene Therapy in CNS Disorder Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Gene Therapy in CNS Disorder Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Gene Therapy in CNS Disorder Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Gene Therapy in CNS Disorder Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Gene Therapy in CNS Disorder Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Gene Therapy in CNS Disorder Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Gene Therapy in CNS Disorder Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Gene Therapy in CNS Disorder
Table 45. Key Market Challenges & Risks of Gene Therapy in CNS Disorder
Table 46. Key Industry Trends of Gene Therapy in CNS Disorder
Table 47. Global Gene Therapy in CNS Disorder Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Gene Therapy in CNS Disorder Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Gene Therapy in CNS Disorder Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Gene Therapy in CNS Disorder Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Voyager Therapeutics Details, Company Type, Gene Therapy in CNS Disorder Area Served and Its Competitors
Table 52. Voyager Therapeutics Gene Therapy in CNS Disorder Product Offered
Table 53. Voyager Therapeutics Gene Therapy in CNS Disorder Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Voyager Therapeutics Main Business
Table 55. Voyager Therapeutics Latest Developments
Table 56. Spark Therapeutics Details, Company Type, Gene Therapy in CNS Disorder Area Served and Its Competitors
Table 57. Spark Therapeutics Gene Therapy in CNS Disorder Product Offered
Table 58. Spark Therapeutics Main Business
Table 59. Spark Therapeutics Gene Therapy in CNS Disorder Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Spark Therapeutics Latest Developments
Table 61. Novartis AG Details, Company Type, Gene Therapy in CNS Disorder Area Served and Its Competitors
Table 62. Novartis AG Gene Therapy in CNS Disorder Product Offered
Table 63. Novartis AG Main Business
Table 64. Novartis AG Gene Therapy in CNS Disorder Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Novartis AG Latest Developments
Table 66. Bluebird Bio Inc. Details, Company Type, Gene Therapy in CNS Disorder Area Served and Its Competitors
Table 67. Bluebird Bio Inc. Gene Therapy in CNS Disorder Product Offered
Table 68. Bluebird Bio Inc. Main Business
Table 69. Bluebird Bio Inc. Gene Therapy in CNS Disorder Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Bluebird Bio Inc. Latest Developments
Table 71. Biogen Details, Company Type, Gene Therapy in CNS Disorder Area Served and Its Competitors
Table 72. Biogen Gene Therapy in CNS Disorder Product Offered
Table 73. Biogen Main Business
Table 74. Biogen Gene Therapy in CNS Disorder Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Biogen Latest Developments
Table 1. Gene Therapy in CNS Disorder Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Viral Gene Therapy
Table 3. Major Players of Non-viral Gene Therapy
Table 4. Gene Therapy in CNS Disorder Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Gene Therapy in CNS Disorder Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Gene Therapy in CNS Disorder Market Size Market Share by Type (2018-2023)
Table 7. Gene Therapy in CNS Disorder Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Gene Therapy in CNS Disorder Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Gene Therapy in CNS Disorder Market Size Market Share by Application (2018-2023)
Table 10. Global Gene Therapy in CNS Disorder Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Gene Therapy in CNS Disorder Revenue Market Share by Player (2018-2023)
Table 12. Gene Therapy in CNS Disorder Key Players Head office and Products Offered
Table 13. Gene Therapy in CNS Disorder Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Gene Therapy in CNS Disorder Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Gene Therapy in CNS Disorder Market Size Market Share by Regions (2018-2023)
Table 18. Global Gene Therapy in CNS Disorder Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Gene Therapy in CNS Disorder Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Gene Therapy in CNS Disorder Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Gene Therapy in CNS Disorder Market Size Market Share by Country (2018-2023)
Table 22. Americas Gene Therapy in CNS Disorder Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Gene Therapy in CNS Disorder Market Size Market Share by Type (2018-2023)
Table 24. Americas Gene Therapy in CNS Disorder Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Gene Therapy in CNS Disorder Market Size Market Share by Application (2018-2023)
Table 26. APAC Gene Therapy in CNS Disorder Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Gene Therapy in CNS Disorder Market Size Market Share by Region (2018-2023)
Table 28. APAC Gene Therapy in CNS Disorder Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Gene Therapy in CNS Disorder Market Size Market Share by Type (2018-2023)
Table 30. APAC Gene Therapy in CNS Disorder Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Gene Therapy in CNS Disorder Market Size Market Share by Application (2018-2023)
Table 32. Europe Gene Therapy in CNS Disorder Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Gene Therapy in CNS Disorder Market Size Market Share by Country (2018-2023)
Table 34. Europe Gene Therapy in CNS Disorder Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Gene Therapy in CNS Disorder Market Size Market Share by Type (2018-2023)
Table 36. Europe Gene Therapy in CNS Disorder Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Gene Therapy in CNS Disorder Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Gene Therapy in CNS Disorder Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Gene Therapy in CNS Disorder Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Gene Therapy in CNS Disorder Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Gene Therapy in CNS Disorder Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Gene Therapy in CNS Disorder Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Gene Therapy in CNS Disorder Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Gene Therapy in CNS Disorder
Table 45. Key Market Challenges & Risks of Gene Therapy in CNS Disorder
Table 46. Key Industry Trends of Gene Therapy in CNS Disorder
Table 47. Global Gene Therapy in CNS Disorder Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Gene Therapy in CNS Disorder Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Gene Therapy in CNS Disorder Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Gene Therapy in CNS Disorder Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Voyager Therapeutics Details, Company Type, Gene Therapy in CNS Disorder Area Served and Its Competitors
Table 52. Voyager Therapeutics Gene Therapy in CNS Disorder Product Offered
Table 53. Voyager Therapeutics Gene Therapy in CNS Disorder Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Voyager Therapeutics Main Business
Table 55. Voyager Therapeutics Latest Developments
Table 56. Spark Therapeutics Details, Company Type, Gene Therapy in CNS Disorder Area Served and Its Competitors
Table 57. Spark Therapeutics Gene Therapy in CNS Disorder Product Offered
Table 58. Spark Therapeutics Main Business
Table 59. Spark Therapeutics Gene Therapy in CNS Disorder Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Spark Therapeutics Latest Developments
Table 61. Novartis AG Details, Company Type, Gene Therapy in CNS Disorder Area Served and Its Competitors
Table 62. Novartis AG Gene Therapy in CNS Disorder Product Offered
Table 63. Novartis AG Main Business
Table 64. Novartis AG Gene Therapy in CNS Disorder Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Novartis AG Latest Developments
Table 66. Bluebird Bio Inc. Details, Company Type, Gene Therapy in CNS Disorder Area Served and Its Competitors
Table 67. Bluebird Bio Inc. Gene Therapy in CNS Disorder Product Offered
Table 68. Bluebird Bio Inc. Main Business
Table 69. Bluebird Bio Inc. Gene Therapy in CNS Disorder Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Bluebird Bio Inc. Latest Developments
Table 71. Biogen Details, Company Type, Gene Therapy in CNS Disorder Area Served and Its Competitors
Table 72. Biogen Gene Therapy in CNS Disorder Product Offered
Table 73. Biogen Main Business
Table 74. Biogen Gene Therapy in CNS Disorder Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Biogen Latest Developments
LIST OF FIGURES
Figure 1. Gene Therapy in CNS Disorder Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Therapy in CNS Disorder Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Gene Therapy in CNS Disorder Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Gene Therapy in CNS Disorder Sales Market Share by Country/Region (2022)
Figure 8. Gene Therapy in CNS Disorder Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Gene Therapy in CNS Disorder Market Size Market Share by Type in 2022
Figure 10. Gene Therapy in CNS Disorder in Alzheimer's Disease
Figure 11. Global Gene Therapy in CNS Disorder Market: Alzheimer's Disease (2018-2023) & ($ Millions)
Figure 12. Gene Therapy in CNS Disorder in Huntington's Disease
Figure 13. Global Gene Therapy in CNS Disorder Market: Huntington's Disease (2018-2023) & ($ Millions)
Figure 14. Gene Therapy in CNS Disorder in Parkinson's Disease
Figure 15. Global Gene Therapy in CNS Disorder Market: Parkinson's Disease (2018-2023) & ($ Millions)
Figure 16. Gene Therapy in CNS Disorder in Batten Disease
Figure 17. Global Gene Therapy in CNS Disorder Market: Batten Disease (2018-2023) & ($ Millions)
Figure 18. Global Gene Therapy in CNS Disorder Market Size Market Share by Application in 2022
Figure 19. Global Gene Therapy in CNS Disorder Revenue Market Share by Player in 2022
Figure 20. Global Gene Therapy in CNS Disorder Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Gene Therapy in CNS Disorder Market Size 2018-2023 ($ Millions)
Figure 22. APAC Gene Therapy in CNS Disorder Market Size 2018-2023 ($ Millions)
Figure 23. Europe Gene Therapy in CNS Disorder Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Gene Therapy in CNS Disorder Market Size 2018-2023 ($ Millions)
Figure 25. Americas Gene Therapy in CNS Disorder Value Market Share by Country in 2022
Figure 26. United States Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Gene Therapy in CNS Disorder Market Size Market Share by Region in 2022
Figure 31. APAC Gene Therapy in CNS Disorder Market Size Market Share by Type in 2022
Figure 32. APAC Gene Therapy in CNS Disorder Market Size Market Share by Application in 2022
Figure 33. China Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Gene Therapy in CNS Disorder Market Size Market Share by Country in 2022
Figure 40. Europe Gene Therapy in CNS Disorder Market Size Market Share by Type (2018-2023)
Figure 41. Europe Gene Therapy in CNS Disorder Market Size Market Share by Application (2018-2023)
Figure 42. Germany Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Gene Therapy in CNS Disorder Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Gene Therapy in CNS Disorder Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Gene Therapy in CNS Disorder Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 56. APAC Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 57. Europe Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 59. United States Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 60. Canada Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 63. China Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 64. Japan Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 65. Korea Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 67. India Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 68. Australia Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 69. Germany Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 70. France Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 71. UK Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 72. Italy Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 73. Russia Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 74. Spain Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 77. Israel Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 80. Global Gene Therapy in CNS Disorder Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Gene Therapy in CNS Disorder Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Gene Therapy in CNS Disorder Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Therapy in CNS Disorder Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Gene Therapy in CNS Disorder Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Gene Therapy in CNS Disorder Sales Market Share by Country/Region (2022)
Figure 8. Gene Therapy in CNS Disorder Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Gene Therapy in CNS Disorder Market Size Market Share by Type in 2022
Figure 10. Gene Therapy in CNS Disorder in Alzheimer's Disease
Figure 11. Global Gene Therapy in CNS Disorder Market: Alzheimer's Disease (2018-2023) & ($ Millions)
Figure 12. Gene Therapy in CNS Disorder in Huntington's Disease
Figure 13. Global Gene Therapy in CNS Disorder Market: Huntington's Disease (2018-2023) & ($ Millions)
Figure 14. Gene Therapy in CNS Disorder in Parkinson's Disease
Figure 15. Global Gene Therapy in CNS Disorder Market: Parkinson's Disease (2018-2023) & ($ Millions)
Figure 16. Gene Therapy in CNS Disorder in Batten Disease
Figure 17. Global Gene Therapy in CNS Disorder Market: Batten Disease (2018-2023) & ($ Millions)
Figure 18. Global Gene Therapy in CNS Disorder Market Size Market Share by Application in 2022
Figure 19. Global Gene Therapy in CNS Disorder Revenue Market Share by Player in 2022
Figure 20. Global Gene Therapy in CNS Disorder Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Gene Therapy in CNS Disorder Market Size 2018-2023 ($ Millions)
Figure 22. APAC Gene Therapy in CNS Disorder Market Size 2018-2023 ($ Millions)
Figure 23. Europe Gene Therapy in CNS Disorder Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Gene Therapy in CNS Disorder Market Size 2018-2023 ($ Millions)
Figure 25. Americas Gene Therapy in CNS Disorder Value Market Share by Country in 2022
Figure 26. United States Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Gene Therapy in CNS Disorder Market Size Market Share by Region in 2022
Figure 31. APAC Gene Therapy in CNS Disorder Market Size Market Share by Type in 2022
Figure 32. APAC Gene Therapy in CNS Disorder Market Size Market Share by Application in 2022
Figure 33. China Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Gene Therapy in CNS Disorder Market Size Market Share by Country in 2022
Figure 40. Europe Gene Therapy in CNS Disorder Market Size Market Share by Type (2018-2023)
Figure 41. Europe Gene Therapy in CNS Disorder Market Size Market Share by Application (2018-2023)
Figure 42. Germany Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Gene Therapy in CNS Disorder Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Gene Therapy in CNS Disorder Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Gene Therapy in CNS Disorder Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Gene Therapy in CNS Disorder Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 56. APAC Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 57. Europe Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 59. United States Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 60. Canada Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 63. China Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 64. Japan Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 65. Korea Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 67. India Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 68. Australia Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 69. Germany Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 70. France Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 71. UK Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 72. Italy Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 73. Russia Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 74. Spain Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 77. Israel Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Gene Therapy in CNS Disorder Market Size 2024-2029 ($ Millions)
Figure 80. Global Gene Therapy in CNS Disorder Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Gene Therapy in CNS Disorder Market Size Market Share Forecast by Application (2024-2029)
